Sunthetics, an AI tech company for chemical and pharmaceutical industries, has raised $4 million in seed funding. L’ATTITUDE Ventures led the round, with support from S3 Ventures, Hearst Level Up Ventures, and the Global Impact Fund II.
The funding will help it to grow its team and improve its machine learning platform, which speeds up the R&D process in pharmaceuticals and chemicals, reducing both time and costs.
Read also – [Funding news] NC-based mPATH Secures $3Million in Funding
Founded by Daniela Blanco, it offers a machine learning platform that uses small datasets (as few as 5 data points) to create a clear, data-driven plan for R&D scientists, helping them achieve faster and better results.
The platform helps streamline experiments and quickly finds the best product options, enabling Sunthetics’ partners to launch new products faster.
About Sunthetics
Sunthetics’ user-friendly machine-learning platform speeds up the development of medicines, materials, chemical processes, and formulations by up to 32 times. Using a unique ML approach, SuntheticsML can work with minimal data (as few as 5 data points) to give R&D scientists powerful and accurate insights for their research.